These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 16827122)

  • 1. PARP regulates TGF-beta receptor type II expression in estrogen receptor-positive breast cancer cell lines.
    Sterling JA; Wu L; Banerji SS
    Anticancer Res; 2006; 26(3A):1893-901. PubMed ID: 16827122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of the transforming growth factor beta type II receptor gene by histone acetyltransferase and deacetylase is mediated by NF-Y in human breast cancer cells.
    Park SH; Lee SR; Kim BC; Cho EA; Patel SP; Kang HB; Sausville EA; Nakanishi O; Trepel JB; Lee BI; Kim SJ
    J Biol Chem; 2002 Feb; 277(7):5168-74. PubMed ID: 11744689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S; Venkatasubbarao K; Li S; Freeman JW
    Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell lines.
    Halder SK; Cho YJ; Datta A; Anumanthan G; Ham AJ; Carbone DP; Datta PK
    Neoplasia; 2011 Oct; 13(10):912-22. PubMed ID: 22028617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Sp1 in the differential expression of transforming growth factor-beta receptor type II in human breast adenocarcinoma MCF-7 cells.
    Liu Y; Zhong X; Li W; Brattain MG; Banerji SS
    J Biol Chem; 2000 Apr; 275(16):12231-6. PubMed ID: 10766860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultraviolet irradiation represses TGF-β type II receptor transcription through a 38-bp sequence in the proximal promoter in human skin fibroblasts.
    He T; Quan T; Fisher GJ
    Exp Dermatol; 2014 Oct; 23 Suppl 1(0 1):2-6. PubMed ID: 25234828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.
    Ko Y; Banerji SS; Liu Y; Li W; Liang J; Soule HD; Pauley RJ; Willson JK; Zborowska E; Brattain MG
    J Cell Physiol; 1998 Aug; 176(2):424-34. PubMed ID: 9648930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARP-1 regulates expression of TGF-β receptors in T cells.
    Zhang P; Nakatsukasa H; Tu E; Kasagi S; Cui K; Ishikawa M; Konkel JE; Maruyama T; Wei G; Abbatiello B; Wang ZQ; Zhao K; Chen W
    Blood; 2013 Sep; 122(13):2224-32. PubMed ID: 23940283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of transforming growth factor beta receptor II in estrogen receptor-negative breast cancer patients.
    Buck MB; Fritz P; Dippon J; Zugmaier G; Knabbe C
    Clin Cancer Res; 2004 Jan; 10(2):491-8. PubMed ID: 14760070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of type II transforming-growth-factor-beta receptors by protein kinase C iota.
    Chuang LY; Guh JY; Liu SF; Hung MY; Liao TN; Chiang TA; Huang JS; Huang YL; Lin CF; Yang YL
    Biochem J; 2003 Oct; 375(Pt 2):385-93. PubMed ID: 12841849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y; Kyprianou N
    Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of transforming growth factor-beta type II receptor reduces tumorigenicity in the human adrenocortical carcinoma SW-13 cell line.
    Yamamoto N; Imai J; Watanabe M; Hiroi N; Sugano S; Yoshino G
    Horm Metab Res; 2006 Mar; 38(3):159-66. PubMed ID: 16673206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells.
    Lee BI; Park SH; Kim JW; Sausville EA; Kim HT; Nakanishi O; Trepel JB; Kim SJ
    Cancer Res; 2001 Feb; 61(3):931-4. PubMed ID: 11221885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ADP-ribose) polymerase as a novel regulator of 17β-estradiol-induced cell growth through a control of the estrogen receptor/IGF-1 receptor/PDZK1 axis.
    Kim H; Tarhuni A; Abd Elmageed ZY; Boulares AH
    J Transl Med; 2015 Jul; 13():233. PubMed ID: 26183824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of one adenine base within the polyadenine tract of transforming growth factor-beta receptor type II in human MDA-MB-231 breast cancer cell line.
    Park B; Jang JS; Park K
    Int J Oncol; 2000 Sep; 17(3):473-8. PubMed ID: 10938386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RANKL treatment releases the negative regulation of the poly(ADP-ribose) polymerase-1 on Tcirg1 gene expression during osteoclastogenesis.
    Beranger GE; Momier D; Rochet N; Quincey D; Guigonis JM; Samson M; Carle GF; Scimeca JC
    J Bone Miner Res; 2006 Nov; 21(11):1757-69. PubMed ID: 17002555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the human transforming growth factor beta type II receptor gene promoter by novel Sp1 sites.
    Jennings R; Alsarraj M; Wright KL; Muñoz-Antonia T
    Oncogene; 2001 Oct; 20(47):6899-909. PubMed ID: 11687969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression and mutations of TGF-beta receptor type II gene in endometrial cancer.
    Sakaguchi J; Kyo S; Kanaya T; Maida Y; Hashimoto M; Nakamura M; Yamada K; Inoue M
    Gynecol Oncol; 2005 Sep; 98(3):427-33. PubMed ID: 15993480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.
    Osada H; Tatematsu Y; Masuda A; Saito T; Sugiyama M; Yanagisawa K; Takahashi T
    Cancer Res; 2001 Nov; 61(22):8331-9. PubMed ID: 11719467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer.
    Zhao H; Shiina H; Greene KL; Li LC; Tanaka Y; Kishi H; Igawa M; Kane CJ; Carroll P; Dahiya R
    Cancer; 2005 Jul; 104(1):44-52. PubMed ID: 15895377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.